Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The efficacy of virus-specific T cells in clearing pathogens involves a fine balance between antiviral and inflammatory features. SARS-CoV-2–specific T cells in individuals who clear SARS-CoV-2 without symptoms could reveal nonpathological yet protective characteristics. We longitudinally studied SARS-CoV-2–specific T cells in a cohort of asymptomatic (n = 85) and symptomatic (n = 75) COVID-19 patients after seroconversion. We quantified T cells reactive to structural proteins (M, NP, and Spike) using ELISpot and cytokine secretion in whole blood. Frequencies of SARS-CoV-2–specific T cells were similar between asymptomatic and symptomatic individuals, but the former showed an increased IFN-γ and IL-2 production. This was associated with a proportional secretion of IL-10 and proinflammatory cytokines (IL-6, TNF-α, and IL-1β) only in asymptomatic infection, while a disproportionate secretion of inflammatory cytokines was triggered by SARS-CoV-2–specific T cell activation in symptomatic individuals. Thus, asymptomatic SARS-CoV-2–infected individuals are not characterized by weak antiviral immunity; on the contrary, they mount a highly functional virus-specific cellular immune response.
Article activity feed
-
SciScore for 10.1101/2020.11.25.399139: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Ethics statement: The study of migrant workers was approved by the Singapore Ministry of Health under Section 59A of the Infectious Diseases Act (2015), thus institutional review board approval was not required and all participants gave verbal consent to participate.
Consent: All COVID-19 patients provided written informed consent and their study was approved by the Institutional Review Boards of NUS (H-20-006), SingHealth (CIRB/F/2018/2387 and CIRB/F/2018/3045) and the National Healthcare Group Domain Specific Review Board (2012/00917).Randomization Study population: The asymptomatic cohort comprised 541 men aged 19-59 years (median 35 years) recruited from … SciScore for 10.1101/2020.11.25.399139: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Ethics statement: The study of migrant workers was approved by the Singapore Ministry of Health under Section 59A of the Infectious Diseases Act (2015), thus institutional review board approval was not required and all participants gave verbal consent to participate.
Consent: All COVID-19 patients provided written informed consent and their study was approved by the Institutional Review Boards of NUS (H-20-006), SingHealth (CIRB/F/2018/2387 and CIRB/F/2018/3045) and the National Healthcare Group Domain Specific Review Board (2012/00917).Randomization Study population: The asymptomatic cohort comprised 541 men aged 19-59 years (median 35 years) recruited from randomly-selected rooms within a SARS-CoV-2 affected dormitory housing over 4000 migrant workers and followed up prospectively from May to July 2020. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Antibody quantification: Sera were tested for anti-nucleoprotein (NP) IgG antibodies (CMIA, Abbott Laboratories) on an Abbott Architect i2000SR automated instrument; a signal to cutoff ratio of ≥1.4 was defined as a positive result following the manufacturer’s recommendation. anti-nucleoprotein (NP) IgGsuggested: NoneELISpot plates (Millipore) were coated with human IFN-γ antibody (1-D1K, Mabtech) overnight at 4ºC. IFN-γsuggested: None), anti-IL-6 (MQ2-13A5), anti-IL-10 (JES3-19F1) and anti-TNF-α (MAb11) antibodies and analyzed on a BD-LSR II FACS Scan. anti-IL-6suggested: Noneanti-IL-10suggested: Noneanti-TNF-αsuggested: NoneSoftware and Algorithms Sentences Resources All COVID-19 patients provided written informed consent and their study was approved by the Institutional Review Boards of NUS (H-20-006), SingHealth (CIRB/F/2018/2387 and CIRB/F/2018/3045) and the National Healthcare Group Domain Specific Review Board (2012/00917). National Healthcaresuggested: NoneAntibody quantification: Sera were tested for anti-nucleoprotein (NP) IgG antibodies (CMIA, Abbott Laboratories) on an Abbott Architect i2000SR automated instrument; a signal to cutoff ratio of ≥1.4 was defined as a positive result following the manufacturer’s recommendation. Abbott Laboratoriessuggested: NoneAbbott Architectsuggested: (Abbott ARCHITECT i1000sr System, RRID:SCR_019328)Data were analyzed by FlowJo (BD Biosciences). FlowJosuggested: (FlowJo, RRID:SCR_008520)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Clearly, this whole blood cytokine assay has limitations, since it does not enable distinction of the cellular source of the different cytokines. However, it provides a holistic snapshot of the virus-specific cellular immunity and can be performed in a large group of asymptomatic individuals tested in a limited time. The results obtained with unsupervised clustering were extremely clear in describing distinct cytokine secretion patterns in symptomatic versus asymptomatic individuals and revealed possible features of SARS-CoV-2-specific T cell responses that are worthy of more detailed characterization in future studies. We observed a high secretion of TNF-α, IL-6, IL-1β and IL-10 exclusively in the blood of a subset of patients who recently recovered from COVID-19, especially in patients with severe COVID-19. The high secretion of pro-inflammatory cytokines was, however, neither proportional to the quantity of IFN-γ and IL-2 detected in the same assay nor to the number of IFN-γ spots detected in the same patients analyzed in parallel with ELISpot. These findings seem to confirm that myeloid cells present in patients who recovered from symptomatic COVID-19 disease have been reprogrammed to promote inflammatory signals and are hyper-responsive to IFNs (30). Secretion of the pro-inflammatory cytokines IL-6, TNF-α, IL-1β was also detected in peptide-stimulated blood of asymptomatic individuals. Yet, their quantity was directly proportional to the quantity of T cell cytokines (IL-...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
-
-
SciScore for 10.1101/2020.11.25.399139: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement All COVID-19 patients provided written informed consent and their study was approved by the Institutional Review Boards of NUS (H-20-006), SingHealth (CIRB/F/2018/2387 and CIRB/F/2018/3045) and the National Healthcare Group Domain Specific Review Board ( Randomization Study population The asymptomatic cohort comprised 541 men aged 19-59 years (median 35 years) recruited from randomly-selected rooms within a SARS-CoV-2 affected dormitory housing over 4000 migrant workers and followed up prospectively from May to July 2020. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Antibody … SciScore for 10.1101/2020.11.25.399139: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement All COVID-19 patients provided written informed consent and their study was approved by the Institutional Review Boards of NUS (H-20-006), SingHealth (CIRB/F/2018/2387 and CIRB/F/2018/3045) and the National Healthcare Group Domain Specific Review Board ( Randomization Study population The asymptomatic cohort comprised 541 men aged 19-59 years (median 35 years) recruited from randomly-selected rooms within a SARS-CoV-2 affected dormitory housing over 4000 migrant workers and followed up prospectively from May to July 2020. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Antibody quantification Sera were tested for anti-nucleoprotein (NP) IgG antibodies (CMIA, Abbott Laboratories) on an Abbott Architect i2000SR automated instrument; a signal to cutoff ratio of ≥1.4 was defined as a positive result following the manufacturer’s recommendation. anti-nucleoprotein ( NP ) IgGsuggested: NoneELISpot plates (Millipore) were coated with human IFN-γ antibody (1-D1K, Mabtech) overnight at 4ºC. IFN-γsuggested: None), anti-IL-6 (MQ2-13A5), anti-IL-10 (JES3-19F1) and anti-TNF-α (MAb11) antibodies and analyzed on a BD-LSR II FACS Scan. anti-IL-6suggested: Noneanti-IL-10suggested: Noneanti-TNF-αsuggested: NoneSoftware and Algorithms Sentences Resources All COVID-19 patients provided written informed consent and their study was approved by the Institutional Review Boards of NUS (H-20-006), SingHealth (CIRB/F/2018/2387 and CIRB/F/2018/3045) and the National Healthcare Group Domain Specific Review Board ( National Healthcaresuggested: NoneAntibody quantification Sera were tested for anti-nucleoprotein (NP) IgG antibodies (CMIA, Abbott Laboratories) on an Abbott Architect i2000SR automated instrument; a signal to cutoff ratio of ≥1.4 was defined as a positive result following the manufacturer’s recommendation. Abbott Laboratoriessuggested: NoneAbbott Architectsuggested: (Abbott ARCHITECT i1000sr System, RRID:SCR_018371)Antibodies were purchased from BD Biosciences- Pharmingen unless otherwise stated. BD Biosciences-suggested: NoneThe results obtained from UMAP analyses were incorporated as additional parameters and converted to .fcs files, which were then loaded into FlowJo to generate heatmaps of cytokine secretion on the reduced dimensions. FlowJosuggested: (FlowJo, RRID:SCR_008520)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
Clearly, this whole blood cytokine assay has limitations, since it does not enable distinction of the cellular source of the different cytokines. However, it provides a holistic snapshot of the virus- specific cellular immunity and can be performed in a large group of asymptomatic individuals tested in a limited time. The results obtained with unsupervised clustering were extremely clear in describing distinct cytokine secretion patterns in symptomatic versus asymptomatic individuals and revealed possible features of SARS-CoV-2-specific T cell responses that are worthy of more detailed characterization in future studies. We observed a high secretion of TNF-α, IL-6, IL-1β and IL-10 exclusively in the blood of a subset of patients who recently recovered from COVID-19, especially in patients with severe COVID-19. The high secretion of pro-inflammatory cytokines was, however, neither proportional to the quantity of IFN-γ and IL-2 detected in the same assay nor to the number of IFN-γ spots detected in the same patients analyzed in parallel with ELISpot. These findings seem to confirm that myeloid cells present in patients who recovered from symptomatic COVID-19 disease have been reprogrammed to promote inflammatory signals and are hyper-responsive to IFNs (30). Secretion of the pro-inflammatory cytokines IL-6, TNF-α, IL-1β was also detected in peptide- stimulated blood of asymptomatic individuals. Yet, their quantity was directly proportional to the quantity of T cell cytokines (I...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
About SciScore
SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.
-